Publications

 

Publications 

HM-2: Water intake disorder in a DEND syndrome afflicted patient with R50P mutation

HM-2: Cell Metabolism – FGF21 Mediates Endocrine Control Of Simple Sugar Intake And Sweet Taste Preference By The Liver

HM-2: Alcohol & Alcoholism – SY15-2SUBCHRONIC LOW DOSE EXENDIN-4 PRETREATMENT INHIBITS RELAPSE TO ALCOHOL DRINKING IN HIGH ALCOHOL PREFERING C57BL6 MICE

HM-2: Physiological and Pathological Impact of Blood Sampling by Retro-Bulbar Sinus Puncture and Facial Vein Phlebotomy in Laboratory Mice

MP-1: Obesity – Liraglutide, a Once-daily Human Glucagon-like Peptide-1 Analog, Minimizes Food Intake in Severely Obese Minipigs

HM-2: Cerebral Markers of the Serotonergic System in Rat Models of Obesity and After Roux-en-Y Gastric Bypass

HM-2: Tesofensine, a Novel Triple Monoamine Reuptake Inhibitor, Induces Appetite Suppression by Indirect Stimulation of α1 Adrenoceptor and Dopamine D1Receptor Pathways in the Diet-Induced Obese Rats

Posters

HM-2: Monitoring food intake in mice with the HM-2 system

HM-2: TESOFENSINE, A NOVEL TRIPLE MONOAMINE REUPTAKE INHIBITOR, INDUCES APPETITE SUPPRESSION BY COMBINED STIMULATION OF α1 ADRENOCEPTOR AND D1 DOPAMINERGIC RECEPTORPATHWAYSINTHEDIET-INDUCEDOBESERAT

Comments are closed